Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

NCT00043043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: celecoxib

Sponsor

National Cancer Institute (NCI)